loadpatents
name:-0.047892093658447
name:-0.017518043518066
name:-0.0064918994903564
Treu; Matthias Patent Filings

Treu; Matthias

Patent Applications and Registrations

Patent applications and USPTO patent grants for Treu; Matthias.The latest application filed is for "tosylacetate based compounds and derivatives thereof as phgdh inhibitors".

Company Profile
3.16.24
  • Treu; Matthias - Vienna AT
  • TREU; Matthias - Wien AT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Tosylacetate based compounds and derivatives thereof as PHGDH inhibitors
Grant 11,304,929 - Weinstabl , et al. April 19, 2
2022-04-19
Tosylacetate Based Compounds And Derivatives Thereof As Phgdh Inhibitors
App 20220008386 - WEINSTABL; Harald ;   et al.
2022-01-13
Annulated 2-amino-3-cyano Thiophenes And Derivatives For The Treatment Of Cancer
App 20210380574 - ABBOTT; Jason ;   et al.
2021-12-09
[1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORS
App 20210332054 - WILDING; Birgit ;   et al.
2021-10-28
5,8-dimethyl-9-phenyl-5,8-dihydro-6H-pyrazolo[3,4-h]quinazolin-2-yl)-(1H-p- yrazol-3-yl)-amines as IGF-1R/IR inhibitors
Grant 10,414,769 - Treu , et al. Sept
2019-09-17
New 5,8-dimethyl-9-phenyl-5,8-dihydro-6h-pyrazolo[3,4-h]quinazolin-2-yl)-(- 1h-pyrazol-3-yl)-amines And Derivatives As Igf-1r/ir Inhibitors
App 20180141948 - TREU; Matthias ;   et al.
2018-05-24
5,8-dihydro-6H-pyrazolo[3,4-h]quinazolines as IGF-1R/IR inhibitors
Grant 9,150,578 - Treu October 6, 2
2015-10-06
Compounds
Grant 8,853,420 - Treu , et al. October 7, 2
2014-10-07
Aminopyrazoloquinazolines
Grant 8,735,386 - Treu May 27, 2
2014-05-27
Compounds
Grant 8,623,887 - Zahn , et al. January 7, 2
2014-01-07
2,4-diamino-pyrimidines As Aurora Inhibitors
App 20130281429 - ZAHN; Stephan Karl ;   et al.
2013-10-24
Benzylic oxindole pyrimidines
Grant 8,546,443 - Treu , et al. October 1, 2
2013-10-01
New 5,8-dihydro-6h-pyrazolo[3,4-h]quinazolines As Igf-1r/ir Inhibitors
App 20130190305 - TREU; Matthias
2013-07-25
Benzylic Oxindole Pyrimidines
App 20120329771 - TREU; Matthias ;   et al.
2012-12-27
Indoline Derivatives And Their Use In Treating Disease-states Such As Cancer
App 20120270859 - TREU; Matthias ;   et al.
2012-10-25
Aminopyrazoloquinazolines
App 20120238542 - Treu; Matthias
2012-09-20
Substituted indolines as tyrosine kinase inhibitors
Grant 8,207,179 - Engelhardt , et al. June 26, 2
2012-06-26
Compounds
App 20110263565 - Treu; Matthias ;   et al.
2011-10-27
2,4-diamino-pyrimidines As Aurora Inhibitors
App 20110251174 - ZAHN; Stephan Karl ;   et al.
2011-10-13
3-(aminomethyliden) 2-indolinone derivates and their use as cell proliferation inhibitors
Grant 7,981,880 - Treu , et al. July 19, 2
2011-07-19
New Compounds
App 20100222331 - Engelhardt; Harald ;   et al.
2010-09-02
Indoline Derivatives And Their Use In Treating Disease-states Such As Cancer
App 20100184747 - Treu; Matthias ;   et al.
2010-07-22
Compounds
App 20100144706 - Zahn; Stephan Karl ;   et al.
2010-06-10
Pyrrolobenzimidazolones and their use as anti-proliferative agents
Grant 7,714,010 - McConnel , et al. May 11, 2
2010-05-11
New compounds
App 20090163467 - Zahn; Stephan Karl ;   et al.
2009-06-25
3- (aminomethyliden) 2-indolinone Derivates And Their Use As Cell Proliferation Inhibitors
App 20090105216 - Treu; Matthias ;   et al.
2009-04-23
2,4-diamino-pyrimidines as aurora inhibitors
App 20070032514 - Zahn; Stephan Karl ;   et al.
2007-02-08
Derivatives and analogs of galanthamine
App 20070027138 - Jordis; Ulrich ;   et al.
2007-02-01
Derivatives and analogs of galanthamine
Grant 7,166,588 - Jordis , et al. January 23, 2
2007-01-23
Alpha-Carbolines as CDK-1 inhibitors
App 20070004684 - Sennhenn; Peter ;   et al.
2007-01-04
Methods for producing norgalanthamine, as well as isomers, salts and hydrates thereof
App 20060069251 - Jordis; Ulrich ;   et al.
2006-03-30
Pyrrolobenzimidazolones and their use as anti-proliferative agents
App 20050261350 - McConnel, Darryl ;   et al.
2005-11-24
Novel derivatives and analogues of galanthamin
App 20030199493 - Jordis, Ulrich ;   et al.
2003-10-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed